PTC Therapeutics Rallies 18% on EU Authorization Update for Translarna

Seeking AlphaMay 20 09:58 ET

Regenxbio(RGNX.US) Officer Sells US$237.22K in Common Stock

$Regenxbio(RGNX.US)$ Officer Mills Kenneth T. sold 15,000 shares of common stock on May 14, 2024 at an average price of $15.8148 for a total value of $237.22K.Source: Announcement What is statement of

moomoo NewsMay 16 17:50 ET

Evaluating Regenxbio: Insights From 9 Financial Analysts

During the last three months, 9 analysts shared their evaluations of Regenxbio (NASDAQ:RGNX), revealing diverse outlooks from bullish to bearish.In the table below, you'll find a summary of their rece

BenzingaMay 15 15:02 ET

REGENXBIO Is Maintained at Buy by HC Wainwright & Co.

REGENXBIO Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 15 11:41 ET

Express News | HC Wainwright & Co. Maintains Buy on Regenxbio, Raises Price Target to $38

BenzingaMay 15 11:31 ET

Regenxbio Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 140.51% HC Wainwright & Co. $36 → $38 Maintains Buy 04/12/2024 153.16% Stifel → $40 Maintains B

BenzingaMay 15 11:29 ET